Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.

In Dermatology
by ClinOwl

In metastatic melanoma, with a dismal survival rate and propensity for treatment resistance and recurrence, it is critical to establish biomarkers that better predict treatment response and disease severity. The […]